National Institutes of Health

" Genomics and Cancer "

General Motors Cancer Research
Annual Scientific Conference

Genomics and Cancer
JUNE 12-13, 2006
Jack Masur Auditorium - Building 10 (Clinical Center)
National Institutes of Health
Bethesda, Maryland

National Institutes of Health
DHHS
NIH Clinical Center
Building 10
Masur Auditorium
Bethesda, Maryland
The Department of Health and Human Services

| Laureate Lecture | Contact Info | NIH Campus |

Full Program
JUNE 12, 2006
  blank
9:00 a.m.
Introduction
Samuel A. Wells, Jr., M.D.
President
General Motors Cancer Research Awards
Professor of Surgery
Duke University Medical Center
Durham, North Carolina
9:05 a.m. Opening Remarks
Elias A. Zerhouni, M.D.
Director
National Institutes of Health
9:15 a.m. Keynote Address
Eric S. Lander, Ph. D.
Member, Whitehead Institute
Professor of Biology
Massachusetts Institute of Technology
Cambridge, Massachusetts
Session I Chromosomal Rearrangements
Moderator Phillip A. Sharp, Ph.D.
Chair, General Motors Cancer Research Awards Committee
Institute Professor
Massachusetts Institute of Technology
Cambridge, Massachusetts
10:15 a.m.

“Genome Form and Function in Breast and Ovarian Cancer”
Joe W. Gray, Ph.D.
Director, Life Sciences Division
Associate Laboratory Director for Life and Environmental Sciences
Lawrence Berkeley National Laboratory
Berkeley, California

10:30 a.m.

Discussion
10:40 a.m. Break
11:00 a.m. “Clinical Significance of Chromosomal Rearrangements in Leukemia”
Clara D. Bloomfield, M.D.
William G. Pace III Professor of Cancer Research
Cancer Scholar and Senior Advisor
Ohio State University Cancer Center
Ohio State University College of Medicine and Public Health
Columbus, Ohio
11:20 a.m.

Discussion

11:30 a.m.

“Copy Number Variation in Cancer and Other Human Disease”
Michael H. Wigler, Ph.D.
Professor
Cold Spring Harbor Laboratory
Cold Spring Harbor, New York

11:50 a.m. Discussion
12:00 p.m.

“MicroRNA Genes in Leukemogenesis”
Carlo M. Croce, M.D.
Director, Genetics Institute
Ohio State University Comprehensive Cancer Center
Columbus, Ohio

12:00 p.m. Discussion
Session II Genome Sequencing for Cancer
Moderator

Carol L. Prives, Ph.D.
DA Costa Professor
Department of Biological Sciences
Columbia University
New York, New York

1:30 p.m.

“Systematic Searches for Somatic Mutations in Human Cancer Genomes”
Michael R. Stratton, MB BS, Ph.D., MRCPath, FMedSci               
Head of the Cancer Genome Project
The Wellcome Trust Sanger Institute
Wellcome Trust Genome Campua
Hinxton, Cambridge, United Kingdom

1:50 p.m. Discussion
2:00 p.m.

“Genomic Studies of Human Lung Carcinoma”
Matthew L. Meyerson, M.D., Ph. D.
Associate Professor of Pathology
Dana-Farber Cancer Institute
Harvard University Medical School
Boston, Massachusetts

2:20 p.m. Discussion
2:30 p.m.

“Mutational Analysis of Signaling Pathways in Human Cancer”
Victor E. Velculescu, M.D., Ph. D.
Assistant Professor of Oncology
Johns Hopkins University School of Medicine
Sidney Kimmel Cancer Center
Baltimore, Maryland                        

2:50 p.m. Discussion
3:00 p.m. Break
Session III Tumor Models
Moderator

Helen Piwnica-Worms, Ph.D.
Professor of Cell Biology and Physiology
Washington University School of Medicine
St. Louis, Missouri

3:30 p.m.

“Oncogene Dependence”
Harold Varmus, M.D.
President and Chief Executive Officer
Memorial Sloan-Kettering Cancer Center
New York, New York

3:50 p.m. Discussion
4:00 p.m.

“Comparative Oncogenomics of Mouse and Human Tumors”
Lynda Chin, Ph.D.
Associate Professor
Harvard University Medical School
Dana-Farber Cancer Institute
Boston, Massachusetts                        

4:20 p.m. Discussion
4:30 p.m. Adjourn

JUNE 13, 2006
Session IV Genomic Instability
Moderator

Elizabeth H. Blackburn, Ph.D.
Professor
Department of Biochemistry and Biophysics
University of California, San Francisco
San Francisco, California

9:00 a.m.

“Recent Adventures with Retrotransposons”
Jef D. Boeke, Ph.D., D. Sc.
Professor and Director
High Throughput Biology Center
Johns Hopkins University School of Medicine
Baltimore, Maryland

9:20 a.m. Discussion
9:30 a.m.

“Telomerase and the Consequences of Telomere Dysfunction”
Carol W. Greider, Ph.D.
Professor and Director
Department of Molecular Biology and Genetics
Johns Hopkins University School of Medicine
Baltimore, Maryland                        

9:50 a.m. Discussion
10:00 a.m.

“Single Nucleotide Polymorphisms in the p53 Pathway”
Arnold J. Levine, Ph.D.
Professor, School of Natural Sciences
Institute for Advanced Study
Princeton University
Princeton, New Jersey

10:20 a.m. Discussion
10:30 a.m. Break
Session V Control of Genome Alterations
Moderator

Robert A. Weinberg, Ph. D.
Professor of Biology
Member, Whitehead Institute
Massachusetts Institute of Technology
Cambridge, Massachusetts

11:00 a.m.

“Mouse Models for Cancer”
Anton Berns, Ph. D.
Director of Research
Chairman of the Board of Directors
Netherlands Cancer Institute
Amsterdam, Netherlands                        

11:20 a.m. Discussion
11:30 a.m.

“Mouse Models of Cancer as a Complex Genetic Trait”
Allan Balmain, Ph.D., F.R.S.e.
Professor
Cancer Research Institute
University of California
San Francisco, California                        

11:50 a.m. Discussion
1:00 p.m. Laureate Lecture

2006 General Motors Cancer Research Award Winner

Napoleone Ferrara, M.D.

Staff Scientist

Department of Molecular Oncology


Genentech, Inc.

 
 

Top

There is no Attendance Fee or Advance Registration Required.
For Information Regarding the General Motors Cancer Research Scientific Conference contact:
Mary Ruemker
E-mail: mary.ruemker@duke.edu
Telephone: 919-684-4056

 

Individuals with disabilities who need sign language interpretation and/or other reasonable accommodation to participate in this conference should contact Paula Cohen (301-496-1776) or the Federal Relay (1-800-877-8339). Requests should be made at least five days in advance of the event.